Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Cancers|November 13, 2021
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular SubtypesRamona Erber, Sareetha Kailayangiri, Hanna Huebner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2019
SS18-SSX-Dependent YAP/TAZ Signaling in Synovial SarcomaIlka Isfort, Magdalene Cyra, Sandra Elges, et al.
Pediatric Blood & Cancer|September 30, 2024
Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Vanessa Mettmann, Stefanie Hecker-Nolting, et al.
Cancer Medicine|September 9, 2025
Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Vanessa Mettmann, Daniel Baumhoer, et al.
Targeted Oncology|June 17, 2022
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II StudyTanya Trippett, Helen Toledano, Quentin Campbell Hewson, et al.
Cancer Immunology Research|February 13, 2015
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantationChristoph Schliemann, Katrin L Gutbrodt, Andrea Kerkhoff, et al.
Scientific Reports|May 24, 2024
Ganglioside SSEA-4 in Ewing sarcoma marks a tumor cell population with aggressive features and is a potential cell-surface immune targetSilke Jamitzky, Bianca Altvater, Carolin Krekeler, et al.
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Blood|January 25, 2015
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCTJudith Feucht, Kathrin Opherk, Peter Lang, et al.
Pageof 15